companydata.dkXGX Pharma ApS: Financial statements 2016
CVR: 32289290
XGX Pharma ApS (CVR 32289290) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 307,092 and a net result of DKK 271,902 compared with DKK -34,858 the year before. Equity amounted to DKK 92,180. The solvency ratio was 10.5%.
- Gross Profit
- 307,092 kr.
- Profit/Loss
- 271,902 kr.
- Equity
- 92,180 kr.
- Total Assets
- 876,843 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 307 t. | 272 t. | 92 t. | - |
| 2015 | - | -33 t. | -35 t. | -180 t. | - |
| 2014 | - | - | -14 t. | -145 t. | - |
| 2013 | - | 145 t. | 145 t. | 130 t. | - |
| 2012 | - | 84 t. | 96 t. | -14 t. | - |
How creditworthy is XGX Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
XGX Pharma ApS has published its annual report for 2015. Gross profit came to DKK -32,643, and the net result was DKK -34,858.
About XGX Pharma ApS
XGX Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens-Nikolaj Schøier. The company is owned by Unimedic Pharma AB. The company has 2 employees. In 2025, the company reported a gross profit of DKK 32,338,381 and a net result of DKK 16,074,119 compared with DKK 4,453,433 the year before. Equity amounted to DKK 30,787,180.